Skip to main content

Six New Members Join WIN Consortium

NEW YORK (GenomeWeb) – The Worldwide Innovative Networking Consortium in personalized cancer medicine today announced the approval of six new members.

The new members are Asan Medical Center in South Korea; Cambridge Cancer Center in the UK; Cancer Research UK; CEO Roundtable on Cancer, headquartered in Cary, NC; the Kimmel Cancer Center at Jefferson in Philadelphia; and Memorial Sloan Kettering Cancer Center in New York.

The WIN Consortium now has 39 member organizations who share a goal of rapidly translating personalized cancer medicine into standards for clinical care. The members share information and conduct multi-institutional, global clinical trials, and research to discover and validate advances in genomic and biomarker-based cancer medicine.

In a statement, Asan Cancer Centre Director Chang Sik Yu said that membership into the consortium "will provide us with the opportunity to promote ground-breaking global clinical trials with other leading organizations to advance personalized cancer medicine. With this opportunity, we hope to make an important contribution to this worldwide effort to overcome cancer."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.